News

Welcome Anaïs Glatard!

We are happy to have Anaïs onboard as a MIDD consultant. Her research experience (from academic groups as well as pharmaceutical companies) includes PK/PD modeling, simulations and dosing individualization. Anaïs will work from our Uppsala office in Sweden. See her bio here.

Read More »

COVID-19 impact


Pharmetheus continues to monitor the challenges presented by the COVID-19 pandemic and its effects on our company and in the field of clinical drug development. Read more about our approach and latest updates here.

Read More »

Benefits with modeling circulating tumor cell counts as a predictor of overall survival

We would like to bring everyone’s attention to a recent publication highlighting the benefits of an innovative quantitative modeling framework. The framework uses circulating tumor cell counts as a predictor of overall survival in metastatic colorectal cancer. Dr. Ida Neldemo (previously Netterberg), main author of the publication, conducted this work before joining Pharmetheus, during her PhD under the supervision of Pharmetheus’ advisors Prof. Mats Karlsson and Prof. Lena Friberg. Find the article here.

Pharmetheus stands ready to apply the principles of this publication to our client’s drug development program.

Read More »

Welcome Ninni Sylenius!

We continue to expand our team with Medical Writers/Quality Control Reviewers. Ninni Sylenius has been working with clinical studies in the cardiovascular field at Uppsala Clinical Research Center, and previously with pharmacovigilance at Novartis and Sanofi Pasteur MSD. She also has experience as a research assistant in cognitive neuroscience and as a community pharmacist. Ninni is based in Stockholm, Sweden.

Read More »

Welcome Viviana Moroso!

We continue to expand our team with Medical Writers/Quality Control Reviewers. Viviana has been working as a freelance medical writer and editor in several clinical fields. Her previous research experience includes database genotype analysis and in vitro work in the field of Immunology of liver transplantation. Viviana is based in Luleå, Sweden.

Read More »

Welcome Mikael Ringh!

We expand our team with Medical Writers/Quality Control Reviewers. Mikael’s research experience includes bioinformatics and biostatistics, applied in autoimmune diseases and CNS disorders. He has previous experience in drug development and production at Roche and GE Healthcare. Mikael is based in Rennes, France. See Mikael’s bio here.

Read More »